Previous Close | 22.39 |
Open | 22.29 |
Bid | 22.44 x 800 |
Ask | 22.45 x 900 |
Day's Range | 21.54 - 22.73 |
52 Week Range | 7.57 - 23.48 |
Volume | |
Avg. Volume | 918,167 |
Market Cap | 1.75B |
Beta (5Y Monthly) | 1.22 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.69 |
Earnings Date | Feb 22, 2023 - Feb 27, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 51.77 |
Subscribe to Yahoo Finance Plus to view Fair Value for RCKT
In this article, we will take a look at the 12 cash-rich small cap stocks to invest in. To see more such companies, go directly to 5 Cash-Rich Small Cap Stocks To Invest In. In 2022, standard diversified portfolios suffered through their worst-performing year in a century. Despite the decline in markets this past year, […]
Rocket Pharmaceuticals (RCKT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
The mean of analysts' price targets for Rocket Pharmaceuticals (RCKT) points to a 163.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.